by Team Small News | Mar 16, 2025 | Pharma, Zydus
The Central Drug Standard Control Organization (CDSCO) has suggested revising the phase III clinical trial protocol for Zydus Healthcare’s Empagliflozin plus Metoprolol Succinate fixed-dose combination (FDC). The CDSCO’s suggestion aims to enhance the...
by Team Small News | Mar 15, 2025 | Pharma, Zydus
Zydus Lifesciences, a leading pharmaceutical company, has successfully completed a USA Food and Drug Administration (USFDA) inspection at its Ankleshwar facility. This achievement demonstrates the company’s commitment to maintaining the highest standards of...
by Team Small News | Mar 14, 2025 | Pfizer, Pharma, Zydus
Zydus, an Indian pharmaceutical company, has made a significant move in the competitive field of sickle cell disease treatment by acquiring a stake in US-based Illexa, a company developing a once-daily oral treatment for the disease. This acquisition provides Zydus...